Literature DB >> 24721110

The role of indoleamine 2,3-dioxygenase (IDO) in immune tolerance: focus on macrophage polarization of THP-1 cells.

Xian-Feng Wang1, Hong-Sheng Wang2, Hao Wang2, Fan Zhang2, Ke-Fang Wang3, Qiang Guo2, Ge Zhang2, Shao-Hui Cai4, Jun Du5.   

Abstract

Macrophages can be divided into two groups as M1 and M2 phenotype. Our results and other groups revealed that IFN-γ can up-regulate the IDO expression and differentiate THP-1 cells to M1 phenotype. Therefore we hypothesized that IDO may play potential roles in macrophage differentiation. Interesting, our results indicated that the ectopic IDO increases the expression of M2 markers such as IL-10 and CXCR4 while decreases the M1 markers such as CCR7 and IL-12p35. In contrast, the knockdown of IDO expression in THP-1 cells resulted in increased M1 markers and lower M2 markers. Our results suggested that the expression intensity of IDO modulates macrophages differentiation. These finding support the counter-regulatory role for IDO with regarding to the polarization of macrophages to restrain excessive or inappropriate immune activation in inflammatory or tumor microenvironment. It throws new light on the mechanisms about the immunosuppressive effect of IDO in tumor or inflammatory diseases.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer therapy; Immune tolerance; Indoleamine 2,3-dioxygenase (IDO); M1; M2

Mesh:

Substances:

Year:  2014        PMID: 24721110     DOI: 10.1016/j.cellimm.2014.02.005

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  60 in total

1.  Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia.

Authors:  Stefania Fiorcari; Silvia Martinelli; Jenny Bulgarelli; Valentina Audrito; Patrizia Zucchini; Elisabetta Colaci; Leonardo Potenza; Franco Narni; Mario Luppi; Silvia Deaglio; Roberto Marasca; Rossana Maffei
Journal:  Haematologica       Date:  2014-11-14       Impact factor: 9.941

Review 2.  Strategies for combining immunotherapy with radiation for anticancer therapy.

Authors:  Steven N Seyedin; Jonathan E Schoenhals; Dean A Lee; Maria A Cortez; Xiaohong Wang; Sharareh Niknam; Chad Tang; David S Hong; Aung Naing; Padmanee Sharma; James P Allison; Joe Y Chang; Daniel R Gomez; John V Heymach; Ritsuko U Komaki; Laurence J Cooper; James W Welsh
Journal:  Immunotherapy       Date:  2015-08-27       Impact factor: 4.196

3.  Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection.

Authors:  Dionna W Williams; Elizabeth L Engle; Erin N Shirk; Suzanne E Queen; Lucio Gama; Joseph L Mankowski; M Christine Zink; Janice E Clements
Journal:  Am J Pathol       Date:  2016-06-18       Impact factor: 4.307

Review 4.  Understanding the tumour micro-environment communication network from an NOS2/COX2 perspective.

Authors:  Debashree Basudhar; Gaurav Bharadwaj; Veena Somasundaram; Robert Y S Cheng; Lisa A Ridnour; Mayumi Fujita; Stephen J Lockett; Stephen K Anderson; Daniel W McVicar; David A Wink
Journal:  Br J Pharmacol       Date:  2018-11-06       Impact factor: 8.739

Review 5.  Targeting TDO in cancer immunotherapy.

Authors:  Cheng-Peng Yu; Yun-Lei Song; Zheng-Ming Zhu; Bo Huang; Ying-Qun Xiao; Da-Ya Luo
Journal:  Med Oncol       Date:  2017-03-29       Impact factor: 3.064

6.  Hypoxia Impairs Mesenchymal Stromal Cell-Induced Macrophage M1 to M2 Transition.

Authors:  Renea A Faulknor; Melissa A Olekson; Emmanuel C Ekwueme; Paulina Krzyszczyk; Joseph W Freeman; François Berthiaume
Journal:  Technology (Singap World Sci)       Date:  2017-06

Review 7.  Addressing the Symptoms or Fixing the Problem? Developing Countermeasures against Normal Tissue Radiation Injury.

Authors:  Jacqueline P Williams; Laura Calvi; Joe V Chakkalakal; Jacob N Finkelstein; M Kerry O'Banion; Edward Puzas
Journal:  Radiat Res       Date:  2016-06-22       Impact factor: 2.841

8.  Paradoxical Pro-inflammatory Responses by Human Macrophages to an Amoebae Host-Adapted Legionella Effector.

Authors:  Christopher Price; Snake Jones; Mirna Mihelcic; Marina Santic; Yousef Abu Kwaik
Journal:  Cell Host Microbe       Date:  2020-03-27       Impact factor: 21.023

9.  Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance).

Authors:  Meenakshi Anurag; Mayanne Zhu; Chen Huang; Suhas Vasaikar; Junkai Wang; Jeremy Hoog; Samantha Burugu; Dongxia Gao; Vera Suman; Xiang H Zhang; Bing Zhang; Torsten Nielsen; Matthew J Ellis
Journal:  J Natl Cancer Inst       Date:  2020-07-01       Impact factor: 13.506

Review 10.  Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism.

Authors:  Ilaria Elia; Marcia C Haigis
Journal:  Nat Metab       Date:  2021-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.